<p>FXR1-WT (▪) and FXR1-KO (□) macrophage cell lines (2.5×10<sup>5</sup> cells) were untreated (Medium) or treated with AA (100 nM) or DHA (100 nM) for 21 h. Cells were also treated with the ERK1/2 inhibitor UO126 (5 µM) concurrently with the AA treatment or stimulated with 50 ng/ml of LPS for 3 h where indicated. Cell supernatants were harvested and levels of TNF were analyzed by ELISA. Results are presented as mean ± SEM of three independent experiments. Differences were analyzed using an unpaired <i>t</i>-test and were considered to be significant at <i>p</i>≤0.05. * indicates <i>p</i><0.05.</p
<p>PD98059, an inhibitor of ERK phosphorylation, enhanced DHA-induced decrease of cell viability. Ce...
<p>(A) L929 cells were treated with TNF in the presence of 20 µM Nec-1 or 50 µM of the Erk inhibitor...
Les anémies liées au cancer et aux inflammations chroniques sont suspectées d'être provoquées par la...
<p>FXR1-WT (▪) and FXR1-KO (□) macrophage cell lines (2.5×10<sup>5</sup> cells) were untreated (Medi...
<p>FXR1-WT (A and C) and FXR1-KO (B and D) macrophage cell lines (1×10<sup>6</sup> cells) were untre...
<p>RAW264.7 cells were pretreated with vehicle control or different inhibitors as indicated in the f...
<p>YAMC cells were untreated (control) or treated with 50 µM BSA-complexed fatty acids (LA or DHA) f...
<p>(A) Protein levels of phosphorylated ERK1/2 and total ERK1/2 were determined by western blot. SCi...
<p>Cells were pre-treated with 50 μM AF for 30 min prior to LPS treatment. After treatment with 100 ...
<p>FXR1-WT (▪) and FXR1-KO (□) macrophage cell lines (1×10<sup>6</sup> cells) were unstimulated (med...
<p>YAMC cells were treated with control or 50 µM BSA-complexed fatty acids (LA or DHA) for 72 h. For...
<p>(A) ω-3 PUFAs increasesα1AMPK protein levels and phosphorylation. Raw264.7 macrophages were treat...
<p>FXR1-WT (▪) and FXR1-KO (□) macrophage cell lines (2.5×10<sup>5</sup> cells) were untreated or tr...
<p>FXR1-WT (▪) macrophages (50×10<sup>6</sup> cells) were treated with either arachidonic acid (100 ...
Background: Uncontrolled inflammation participates in the development of inflammatory diseases. Bene...
<p>PD98059, an inhibitor of ERK phosphorylation, enhanced DHA-induced decrease of cell viability. Ce...
<p>(A) L929 cells were treated with TNF in the presence of 20 µM Nec-1 or 50 µM of the Erk inhibitor...
Les anémies liées au cancer et aux inflammations chroniques sont suspectées d'être provoquées par la...
<p>FXR1-WT (▪) and FXR1-KO (□) macrophage cell lines (2.5×10<sup>5</sup> cells) were untreated (Medi...
<p>FXR1-WT (A and C) and FXR1-KO (B and D) macrophage cell lines (1×10<sup>6</sup> cells) were untre...
<p>RAW264.7 cells were pretreated with vehicle control or different inhibitors as indicated in the f...
<p>YAMC cells were untreated (control) or treated with 50 µM BSA-complexed fatty acids (LA or DHA) f...
<p>(A) Protein levels of phosphorylated ERK1/2 and total ERK1/2 were determined by western blot. SCi...
<p>Cells were pre-treated with 50 μM AF for 30 min prior to LPS treatment. After treatment with 100 ...
<p>FXR1-WT (▪) and FXR1-KO (□) macrophage cell lines (1×10<sup>6</sup> cells) were unstimulated (med...
<p>YAMC cells were treated with control or 50 µM BSA-complexed fatty acids (LA or DHA) for 72 h. For...
<p>(A) ω-3 PUFAs increasesα1AMPK protein levels and phosphorylation. Raw264.7 macrophages were treat...
<p>FXR1-WT (▪) and FXR1-KO (□) macrophage cell lines (2.5×10<sup>5</sup> cells) were untreated or tr...
<p>FXR1-WT (▪) macrophages (50×10<sup>6</sup> cells) were treated with either arachidonic acid (100 ...
Background: Uncontrolled inflammation participates in the development of inflammatory diseases. Bene...
<p>PD98059, an inhibitor of ERK phosphorylation, enhanced DHA-induced decrease of cell viability. Ce...
<p>(A) L929 cells were treated with TNF in the presence of 20 µM Nec-1 or 50 µM of the Erk inhibitor...
Les anémies liées au cancer et aux inflammations chroniques sont suspectées d'être provoquées par la...